WCN26-5848 Metanephric Graft Development under Diabetes and HIF-PHD Inhibition toward Xenogeneic Renal Regenerative Therapy

Read full text Summarise with VIRAT
Authors: Nagisa Koda, Kei Matsumoto, Toyoshi Seito, Hinari Ohashi, Takafumi Kuroda, Takumi Ikeda, Shutaro Yamamoto, Keita Morimoto, Yuka Inage, Yatsumu Saito, Shohei Fukunaga, Toshinari Fujimoto
+3 more Susumu Tajiri, Shuichiro Yamanaka, Takashi Yokoo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic kidney disease (CKD) affects over 800 million people worldwide, and diabetic nephropathy is the leading cause of dialysis in Japan. Once end-stage renal failure occurs, dialysis is required, severely reducing quality of life, while donor shortage limits kidney transplantation—the only curative therapy. Xenogeneic regenerative medicine may overcome these challenges by generating functional kidneys

Fields of Study & Subjects

Renal and related cancers Xenotransplantation and immune response Tissue Engineering and Regenerative Medicine

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105504–105504
Publication date
25 March 2026
Language
EN